KR20080108366A - Ｕｖｂ-유발 피부손상 방지 방법 - Google Patents

Ｕｖｂ-유발 피부손상 방지 방법 Download PDF

Info

Publication number
KR20080108366A
KR20080108366A KR1020087028640A KR20087028640A KR20080108366A KR 20080108366 A KR20080108366 A KR 20080108366A KR 1020087028640 A KR1020087028640 A KR 1020087028640A KR 20087028640 A KR20087028640 A KR 20087028640A KR 20080108366 A KR20080108366 A KR 20080108366A
Authority
KR
South Korea
Prior art keywords
tsp
subject
uvb
induced
wrinkles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087028640A
Other languages
English (en)
Korean (ko)
Inventor
야노 기이치로
제이. 데트마 마이클
Original Assignee
더 제너럴 하스피탈 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 제너럴 하스피탈 코포레이션 filed Critical 더 제너럴 하스피탈 코포레이션
Publication of KR20080108366A publication Critical patent/KR20080108366A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020087028640A 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법 Ceased KR20080108366A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
US60/283,874 2001-04-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7013393A Division KR20040021598A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법

Publications (1)

Publication Number Publication Date
KR20080108366A true KR20080108366A (ko) 2008-12-12

Family

ID=23087934

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020087028640A Ceased KR20080108366A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법
KR10-2003-7013393A Ceased KR20040021598A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR10-2003-7013393A Ceased KR20040021598A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법

Country Status (8)

Country Link
US (1) US6712617B2 (enExample)
EP (1) EP1377253A4 (enExample)
JP (1) JP2004526758A (enExample)
KR (2) KR20080108366A (enExample)
CN (1) CN100340287C (enExample)
CA (1) CA2446093A1 (enExample)
TW (1) TWI233361B (enExample)
WO (1) WO2002083088A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
CN100574743C (zh) * 2002-06-25 2009-12-30 株式会社资生堂 抗老化剂
RU2338741C2 (ru) * 2002-07-31 2008-11-20 Мершан Корпорейшн Новые физиологически активные вещества
US7576204B2 (en) * 2002-07-31 2009-08-18 Mercian Corporation Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same
WO2004032963A2 (en) 2002-10-04 2004-04-22 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
RU2330069C2 (ru) * 2002-11-29 2008-07-27 Мершан Корпорейшн Способ получения макролидного соединения и штаммы streptomyces sp., mortierella sp. и micromonosporaceae
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
CN101057438A (zh) 2004-10-12 2007-10-17 阿瓦雷公司 电信环境中的资源共享
BRPI0613548A2 (pt) * 2005-05-05 2011-01-18 Genencor Int composições de cuidado pessoal e métodos para seu uso
US20090220627A1 (en) * 2005-09-16 2009-09-03 Kiyotaka Hasegawa Novel vascular endothelial growth factor expression inhibitors
JP2009523807A (ja) 2006-01-18 2009-06-25 ザ ジェネラル ホスピタル コーポレイション リンパ機能を高める方法
JP2009533973A (ja) 2006-04-12 2009-09-17 アウェア， インコーポレイテッド パケット再送信ならびにメモリの共有
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
JPWO2008020584A1 (ja) * 2006-08-14 2010-01-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定な凍結乾燥製剤
US7790887B2 (en) * 2007-01-29 2010-09-07 Eisai R&D Management Co., Ltd. Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
TW200918099A (en) 2007-09-14 2009-05-01 Nitto Denko Corp Drug carriers
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
WO2011040496A1 (ja) 2009-09-30 2011-04-07 株式会社資生堂 ヘパラナーゼ活性阻害剤
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
EP4081241A4 (en) 2019-12-24 2024-05-01 Juvena Therapeutics, Inc. REGENERATIVE POLYPEPTIDES AND USES THEREOF
EP4359425B1 (en) 2021-06-21 2026-08-05 Juvena Therapeutics, Inc. Igf2 fusion polypeptide and use in the treatment of muscular dystrophy, sarcopenia, cachexia, or muscle injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
ES2301197T3 (es) * 1997-05-27 2008-06-16 Sembiosys Genetics Inc. Utilizaciones de cuerpos oleosos.
AU1597199A (en) * 1997-11-25 1999-06-15 Cornell Research Foundation Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
KR20010105403A (ko) * 1999-03-31 2001-11-28 마빈 씨. 구트리 트롬보스폰딘-2 및 이의 용도
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Also Published As

Publication number Publication date
WO2002083088A1 (en) 2002-10-24
US6712617B2 (en) 2004-03-30
EP1377253A1 (en) 2004-01-07
TWI233361B (en) 2005-06-01
US20030008821A1 (en) 2003-01-09
JP2004526758A (ja) 2004-09-02
KR20040021598A (ko) 2004-03-10
CA2446093A1 (en) 2002-10-24
EP1377253A4 (en) 2008-09-03
CN100340287C (zh) 2007-10-03
CN1512868A (zh) 2004-07-14

Similar Documents

Publication Publication Date Title
KR20040021598A (ko) Ｕｖｂ-유발 피부손상 방지 방법
JP5960749B2 (ja) 毛の成長を調節する方法
US6773881B2 (en) Methods of modulating hair growth
Hasan et al. Coordinate expression of NGF and α-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats
US20020086013A1 (en) Methods of modulating fibrosis
AU2001253012A1 (en) Methods of modulating hair growth
JPH09509825A (ja) 骨細胞を刺激するための方法および組成物
JP2008530003A (ja) 創傷治癒を向上させるための、および線維症予防のためのミオスタチン（ｇｄｆ−８）アンタゴニストの使用
Hanakawa et al. Desmogleins 1 and 3 in the companion layer anchor mouse anagen hair to the follicle
US20100247627A1 (en) Foxn1 and pigmentation
KR20070046064A (ko) 피부 손상 방지
CN110997708A (zh) 人bmp7蛋白的变体
TW200302109A (en) Methods and compositions for the promotion of hair growth utilizing actin binding peptides
US20020048582A1 (en) Methods of modulating angiogenesis
EP0778779B1 (en) Methods of inducing hair growth and coloration
US20050281761A1 (en) Methods of preventing UVB-induced skin damage
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage
Offutt et al. John Foley1, 2, 3,*, A. Godwin Diamond', Ryan M. Gonterman1
HK40027691A (en) Variants of human bmp7 protein

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20081124

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20081223

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20090123

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100903

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20110930

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20100903

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20090123

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I